# Shandong Xinhua Pharmaceutical Co., Ltd., China – FDA Inspections

Source: https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-co-ltd/acea3619-5739-4a9f-a4b2-82e0207194b3

> Inspection records and compliance data for Shandong Xinhua Pharmaceutical Co., Ltd. in -. 4 FDA inspections on record, last inspected September 15, 2023.

---

## Details

- Name: Shandong Xinhua Pharmaceutical Co., Ltd.
- FEI Number: 3002808153
- Business Operations: API MANUFACTURE
- State: -
- Zip Code: -
- Country Name: China
- Address: - -, China
- Country: China

## Related Documents

- [EIR - Shandong Xinhua Pharmaceutical Co., Ltd. - 2023-09-15](https://www.keypedia.com/records/eir/shandong-xinhua-pharmaceutical-co-ltd/8eef5512-2c32-4f74-9329-18efe1e2dc0a) — source: FDA, date: September 15, 2023
- FDA Inspection 1220079 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2023-09-15 — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2023
- FDA Inspection 1220079 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2023-09-15 — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2023
- FDA Inspection 1000050 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2016-03-31 — classification: No Action Indicated (NAI), source: FDA, date: March 31, 2016
- FDA Inspection 875678 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2014-04-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2014
- FDA Inspection 875678 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2014-04-04 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 4, 2014
- [FDA Inspection 685447 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2010-07-13](https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-co-ltd/a8738310-448f-4632-be4a-269532fbd6ff) — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2010
- FDA Inspection 685447 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2010-07-13 — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2010
- FDA Inspection 685447 - Shandong Xinhua Pharmaceutical Co., Ltd. - 2010-07-13 — classification: No Action Indicated (NAI), source: FDA, date: July 13, 2010

## Related Companies

- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Zhejiang Jiuzhou Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-jiuzhou-pharmaceutical-co-ltd/6ff21ff3-4c18-4e07-9c38-79e499bfb8fa)
- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)
- [Dottikon Exclusive Synthesis AG](https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074)
- [PolyPeptide Laboratories, Inc.](https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Livzon Group (Ningxia) Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-group-ningxia-pharmaceutical-co-ltd/78a1f9d4-41d0-440a-87bc-8c9521d0159a)
- [Novacyl](https://www.keypedia.com/companies/novacyl/928b015a-ee45-4383-ad21-070b43308727)
- [Bachem Americas, Inc.](https://www.keypedia.com/companies/bachem-americas-inc/3a9656ad-737b-4682-9ab3-951b1041002e)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/5f1fa8da-b68a-4d31-bbfa-2aba62e8a4d1)
- [Minakem Beuvry Production SAS](https://www.keypedia.com/companies/minakem-beuvry-production-sas/8fb2d8e7-cb14-4356-8902-bb679852c669)

## Related Officers

- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)
- [Investigator](https://www.keypedia.com/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)
